Breast Cancer Vaccine
A Tat fusion protein-based tumor vaccine for breast cancer developed
Published in Vaccine Weekly, August 10th, 2005
A study from the United States recently reported "that dendritic cells (DCs) transduced with a fusion protein between Her2/neu and the protein transduction domain Tat (DC-Tat-extracellular domain [ECD]) induced Her2/neu-specific CD8+ T cells in vitro. This study tested the in vivo efficacy of DC-Tat-ECD in a murine breast cancer model.
"FVB/N mice received 1 or 2 weekly intraperitoneal immunizations with syngeneic DC-Tat-ECD followed by a tumor challenge with syngeneic neu+ breast cancer cells, and tumor development was monitored. To test for Her2/neu specificity,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-10)
More Articles from Vaccine Weekly
- Chickenpox Vaccine
Oka/GSK attenuated varicella vaccine prevents chickenpox in clinical practice - HIV/AIDS Vaccine
Cross-reactivity of anti-HIV immune responses of major HIV-1 clades reported - Monoclonal Antibodies
Plant biopharming of monoclonal antibodies reviewed - Vector Development
Intracarotid delivery of oncolytic HSV vector to brain cancer reported - Animal Models
Nonhuman primates are models for hematology, immunology, and virology studies - Anthrax Vaccine
Oral spore vaccine based on Bacillus anthracis antigen developed - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
